Track topics on Twitter Track topics that are important to you
For the last few decades, clinicians have been trying to figure out how to decrease therapy in patients with rheumatoid arthritis who have reached stable remission. Various strategies for tapering or discontinuing treatment altogether have been explored to inconclusive results. This is not to say tapering therapy has been unsuccessful or discontinuing absolutely leads to immediate or uncontrollable flare. Flares happen and re-initiation of treatment is often necessary. Therefore, the questions at hand pertain to timing, dosage levels, clinical decision-making, and the interplay between steroid and biologic therapies. Paul Emery, MD, professor of rheumatology, director of The Leeds Institute of Rheumatic and Musculoskeletal Medicine and director of the Leeds Musculoskeletal Biomedical Research Unit at Leeds Teaching Hospital NHS Trust, outlined the basics of the discussion.NEXT ARTICLE
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...